Indication
Metastatic Malignant Neoplasm in the Thoracic Cavity
1 clinical trial
2 products
1 drug
Clinical trial
Phase I/II Trial of Ipilimumab or Nivolumab With BMS-986156 and Hypofractionated Stereotactic Radiation Therapy in Patients With Advanced Solid MalignanciesStatus: Active (not recruiting), Estimated PCD: 2024-08-29
Product
BMS-986156Product
IpilimumabDrug
T-VEC